The original antibody was developed by isolating heavy and light chain cDNAs from a hybridoma producing an anti-GD3 IgM antibody. These sequences were then codon-optimized and transfected into CHO cells to produce the recombinant PolrecCHOIgM/GD3 antibody.
Klonalität:
Monoclonal
Klon-Bezeichnung:
[PolrecCHOIgM/GD3]
Puffer:
PBS with 0.02% Proclin 300.
Target-Kategorie:
tumor-associated gangliosides
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten